1: Scurachio RS, Santos WG, Nascimento ES, Skibsted LH, Cardoso DR. Isomerization of Cholecalciferol through Energy Transfer as a Protective Mechanism Against Flavin-Sensitized Photooxidation. J Agric Food Chem. 2015 May 13;63(18):4629-37. doi: 10.1021/jf505958c. Epub 2015 Apr 29. PMID: 25891983.
2: Wojtkielewicz A, Morzycki JW. Synthesis of gamma- and delta-lactones from 1alpha-hydroxy-5,6-trans-vitamin D3 by ring-closing metathesis route and their reduction with metal hydrides. Steroids. 2007 Jun;72(6-7):552-8. doi: 10.1016/j.steroids.2007.03.005. Epub 2007 Mar 18. PMID: 17493648.
3: Swami S, Zhao XY, Sarabia S, Siu-Caldera ML, Uskokovic M, Reddy SG, Feldman D. A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). Recent Results Cancer Res. 2003;164:349-52. doi: 10.1007/978-3-642-55580-0_24. PMID: 12899533.
4: Chen TC, Persons KS, Lu Z, Mathieu JS, Holick MF. An evaluation of the biologic activity and vitamin D receptor binding affinity of the photoisomers of vitamin D3 and previtamin D3. J Nutr Biochem. 2000 May;11(5):267-72. doi: 10.1016/s0955-2863(00)00077-2. PMID: 10876100.
5: Wecksler WR, Norman AW. Studies on the mode of action of calciferol XXV. 1 alpha,25-dihydroxy-5,6-trans-vitamin D3, the 5E-isomer of 1 alpha,25-dihydroxyvitamin D3. Steroids. 1980 Apr;35(4):419-25. doi: 10.1016/0039-128x(80)90142-7. PMID: 6246662.
6: Mouriño A, Blair P, Wecksler W, Johnson RL, Norman AW, Okamura WH. Studies on vitamin D (calciferol) and its analogues. 15. 24-Nor-1alpha,25-dihydroxyvitamin D3 and 24-nor-25-hydroxy-5,6-trans-vitamin D3. J Med Chem. 1978 Oct;21(10):1025-9. doi: 10.1021/jm00208a005. PMID: 214553.
7: Hofsass H, Alicino NJ, Hirsch AL, Ameika L, Smith LD. Comparison of high pressure liquid chromatographic and chemical methods for vitamin D3 concentrates. II. Collaborative study. J Assoc Off Anal Chem. 1978 May;61(3):735-45. PMID: 206533.
8: Borsje B, Heyting A, Roborgh JR, Ross DB, Shillam KW. Analysis of fat-soluble vitamins. XVI. Antirachitic activity of 5,6-trans-vitamin D3 alone and in the presence of 5,6-cis-vitamin D3 resin, using chick bioassays. J Assoc Off Anal Chem. 1977 Sep;60(5):1003-9. PMID: 197056.
9: Okamura WH, Hammond ML, Rego A, Norman AW, Wing RM. Studies on vitamin D (calciferol) and its analogues. 12. Structural and synthetic studies of 5,6-trans-vitamin D3 and the stereoisomers of 10,19-dihydrovitamin D3 including dihydrotachysterol3. J Org Chem. 1977 Jun 24;42(13):2284-91. doi: 10.1021/jo00433a021. PMID: 195026.
10: Kobayashi T, Moriuchi S, Shimura F, Katsui G. Synthesis and biological activity of 5,6-trans-vitamin D3 in anephric rats. J Nutr Sci Vitaminol (Tokyo). 1976;22(4):299-306. doi: 10.3177/jnsv.22.299. PMID: 189003.
11: Stern PH, Trummel CL, Schnoes HK, Deluca HF. Bone resorbing activity of vitamin D metabolites and congeners in vitro: influence of hydroxyl substituents in the A ring. Endocrinology. 1975 Dec;97(6):1552-8. doi: 10.1210/endo-97-6-1552. PMID: 1204577.
12: Rutherford WE, Hruska K, Blondin J, Holick M, DeLuca H, Klahr S, Slatopolsky E. The effect of 5,6-trans vitamin D3 on calcium absorption in chronic renal disease. J Clin Endocrinol Metab. 1975 Jan;40(1):13-18. doi: 10.1210/jcem-40-1-13. PMID: 1112871.
13: Tsukida K, Akutsu K, Saiki K. Carbon-13 nuclear magnetic resonance spectra of vitamins D and related compounds. J Nutr Sci Vitaminol (Tokyo). 1975;21(6):411-20. doi: 10.3177/jnsv.21.411. PMID: 178846.
14: Gagnon R, Ogden GW, Just G, Kaye M. Comparison of dihydrotachysterol and 5,6-trans vitamin D3 on intestinal calcium absorption in patients with chronic renal failure. Can J Physiol Pharmacol. 1974 Apr;52(2):272-4. doi: 10.1139/y74-037. PMID: 4365509.